Literature DB >> 21706346

Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors.

N Oudah1, Z Al Duhailib, K Alsaad, S Qurashi, G Ghamdi, A Flaiw, F Hejaili, M Farooqui, A Al Sayyari.   

Abstract

The aim of this study is to investigate the clinical and pathological features and outcome of glomerulonephritis with crescents among adult patients. This is a retrospective study of all cases of crescentic GN seen over a 9-year period (2001-2010). Histological features were assessed, and renal function at baseline and end of follow-up period was recorded. Results among different etiological groups at baseline and end of follow-up period were compared. The mean age in the whole group was 35.6 years (16.2), with the lowest mean in the lupus nephritis (LN) group [27.7 years (9.9)] and the highest in the pauciimmune glomerulonephritis (PIGN) group (P = 0.001). There were 72 cases enrolled in the study. LN accounted for 49.3% of the cases, PIGN for 26.5%, other immune complex glomerulonephritis (ICGN) for 19% and post-infectious GN accounted for 6.3% The majority (85.7%) of the patients had renal impairment at presentation (mean serum creatinine levels were 247 (85) μmol/l, 412 (75) μmol/l and 230 (141) μmol/l in LN, PICN and ICGN, respectively (P = 0.05). Women accounted for 85.3, 76.5 and 36.2% of the patients in LN, PICN and ICGN, respectively (P = 0.025). By the end of the follow-up period of 26 (22.9) months, 25.8% of the patients were requiring dialysis (16.70% in the LN group, 50% in PIGN and 25% in ICGN (P = 0.05) and 21.7% had nephrotic range proteinuria (16.7, 1 and 33.3%, respectively (P = 0.4). Using logistic multivariate analysis, the only independent factors found to predict need for dialysis of prognosis were percent of sclerosed glomeruli (P = 0.05) and presence of ATN (P = 0.028). Baseline proteinuria or SCr, gender and number of glomeruli with crescents, on the other hand, did not impact prognosis. Using linear regression multivariate analysis, SCr, protein excretion and activity score at biopsy did not influence change in SCr or final SCr during the follow-up period. Using ANOVA to compare the groups of LN, PIGN and ICGN), we found significant differences only in gender between LN and ICGN (P = 0.035), in percent glomerular global sclerosis (between LN and PIGN (P = 0.007) and between LN and ICGN (P = 0.012) and in age (between LN and PIGN (P = 0.006). Almost half of our patients with CrGN were due to LN which is higher than that reported by others where PIGN was the more prevalent etiology. Patients with PICN were older and had worse prognosis. This could be explained by the higher number of globally sclerosed glomeruli in the PIGN group.

Entities:  

Mesh:

Year:  2011        PMID: 21706346     DOI: 10.1007/s10238-011-0147-4

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  22 in total

1.  Rapidly progressive crescentic glomerulonephritis.

Authors:  J Charles Jennette
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

2.  Clinical pattern of systemic lupus erythematosus in Western Saudi Arabia.

Authors:  Faiza A Qari
Journal:  Saudi Med J       Date:  2002-10       Impact factor: 1.484

Review 3.  Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Authors:  Anthony D Booth; Mike K Almond; Aine Burns; Peter Ellis; Gill Gaskin; Guy H Neild; Martin Plaisance; Charles D Pusey; David R W Jayne
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

4.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Authors:  S L Hogan; P H Nachman; A S Wilkman; J C Jennette; R J Falk
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

5.  Glomerulonephritis in saudi arabia: a review.

Authors:  A H Mitwalli
Journal:  Saudi J Kidney Dis Transpl       Date:  2000 Oct-Dec

6.  The spectrum of glomerulonephritis in saudi arabia: the results of the saudi registry.

Authors:  S Huraib; A Al Khader; F A Shaheen; H Abu Aisha; M Z Souqiyyeh; F Al Mohana; M Soliman; J Al Wakeel; A Mitwalli; S Al Mohaya; R Said; L Al Menawy; M Sohaibani; N Chan
Journal:  Saudi J Kidney Dis Transpl       Date:  2000 Jul-Sep

7.  Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis.

Authors:  Juan M López-Gómez; Francisco Rivera
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 8.237

8.  Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients.

Authors:  Stasa Kaplan-Pavlovcic; Kristina Cerk; Radoslav Kveder; Jelka Lindic; Alenka Vizjak
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992

9.  Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population.

Authors:  T Heller; M Ahmed; A Siddiqqi; C Wallrauch; S Bahlas
Journal:  Lupus       Date:  2007       Impact factor: 2.911

10.  Clinicopathological study of the WHO classification in childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciaran Duffy; Chantal Bernard; Rosie Scuccimarri; Karen Watanabe Duffy; Rhoda Kagan; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2004-03-12       Impact factor: 3.714

View more
  5 in total

1.  Crescentic glomerulonephritis: what's different in South Asia? A single center observational cohort study.

Authors:  Suceena Alexander; Sabina Yusuf; Gautham Rajan; Elenjickal Elias John; Sanjeet Roy; V C Annamalai; Athul Thomas; Jeethu Joseph Eapen; Anna T Valson; Vinoi George David; Santosh Varughese
Journal:  Wellcome Open Res       Date:  2020-07-08

2.  Analysis of Various Types of Glomerulonephritis with Crescents at a Single Center.

Authors:  Tomo Nakakita; Kenichi Akiyama; Kazunori Karasawa; Yoei Miyabe; Takahito Moriyama; Keiko Uchida; Kosaku Nitta
Journal:  Int J Nephrol       Date:  2022-05-09

3.  Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis.

Authors:  Ting Wu; Jiajia Peng; Ting Meng; Qianqian Liu; Xiang Ao; Wei Lin; Hongling Yin; Jinbiao Chen; Jiaxi Pu; Zhangzhe Peng; Weisheng Peng; Xiaozhao Li; Xiangcheng Xiao; Qiaoling Zhou; Yong Zhong; Ping Xiao
Journal:  Exp Ther Med       Date:  2019-09-18       Impact factor: 2.447

4.  Clinicopathological Characteristics and Outcomes of Diffuse Crescentic Glomerulonephritis - A Single Center Experience from Southern India.

Authors:  Shankar Prasad Nagaraju; Sindhura Lakshmi Koulmane Laxminarayana; Srinivas Kosuru; Rajeevalochana Parthasarathy; Ravindra Prabhu Attur; Dharshan Rangaswamy; Uday Venkat Matteti; Vasudeva Guddattu
Journal:  J Clin Diagn Res       Date:  2017-09-01

5.  Clinical spectrum and outcomes of crescentic glomerulonephritis: A single center experience.

Authors:  S K Rampelli; N G Rajesh; B H Srinivas; K T Harichandra Kumar; R P Swaminathan; P S Priyamvada
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.